# Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

> **NCT03727061** · PHASE1 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 5 (actual)

## Conditions studied

- Recurrent Head and Neck Carcinoma
- Locally Advanced Head and Neck Carcinoma

## Interventions

- **BIOLOGICAL:** Nivolumab
- **DRUG:** Porfimer Sodium
- **PROCEDURE:** Interstitial Illumination Photodynamic Therapy
- **OTHER:** Quality of Life Assessment

## Key facts

- **NCT ID:** NCT03727061
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-10
- **Primary completion:** 2024-10-22
- **Final completion:** 2024-10-22
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2025-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03727061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03727061, "Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03727061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*